ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
3.530
-0.110 (-3.02%)
Nov 6, 2024, 4:00 PM EST - Market closed
ImmuCell Employees
As of December 31, 2023, ImmuCell had 79 total employees, including 74 full-time and 5 part-time employees. The number of employees increased by 5 or 6.76% compared to the previous year.
Employees
79
Change (1Y)
5
Growth (1Y)
6.76%
Revenue / Employee
$293,961
Profits / Employee
-$51,257
Market Cap
27.65M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Burning Rock Biotech | 786 |
DarioHealth | 294 |
Enlivex Therapeutics | 71 |
IGC Pharma | 67 |
MiNK Therapeutics | 31 |
NeuroOne Medical Technologies | 16 |
BriaCell Therapeutics | 16 |
Iterum Therapeutics | 14 |
ICCC News
- 4 weeks ago - ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2024 - GlobeNewsWire
- 3 months ago - ImmuCell Corporation (ICCC) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2024 - GlobeNewsWire
- 3 months ago - ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2024 - GlobeNewsWire
- 4 months ago - ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2024 - GlobeNewsWire
- 5 months ago - ImmuCell Provides Update on Regulatory Status of Product Development Initiative for Re-Tain® - GlobeNewsWire
- 5 months ago - ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders - GlobeNewsWire
- 6 months ago - ImmuCell Corporation (ICCC) Q1 2024 Earnings Call Transcript - Seeking Alpha